Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy.

Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy. Abstract Text:

    punniyakoti t veeraveeduPunniyakoti T Veeraveedu,kenichi watanabeKenichi Watanabe,meilei maMeilei Ma,suresh s palaniyandiSuresh S Palaniyandi,ken'ichi yamaguchiKen'ichi Yamaguchi,kenji suzukiKenji Suzuki,makoto kodamaMakoto Kodama,yoshifusa aizawaYoshifusa Aizawa,punniyakoti t veeraveeduPunniyakoti T Veeraveedu,kenichi watanabeKenichi Watanabe,meilei maMeilei Ma,suresh s palaniyandiSuresh S Palaniyandi,ken'ichi yamaguchiKen'ichi Yamaguchi,kenji suzukiKenji Suzuki,makoto kodamaMakoto Kodama,yoshifusa aizawaYoshifusa Aizawa,

    Torasemide is a long-acting loop diuretic that combines the effects of both furosemide and spironolactone. It has been reported that torasemide may block the renin-angiotensin-aldosterone system and therefore it might attenuate myocardial remodeling accompanied by left ventricular dysfunction. However, nothing is known about the effect of torasemide on myocardial remodeling in a rat model in which myosin-induced experimental autoimmune myocarditis might develop into dilated cardiomyopathy. Experimental autoimmune myocarditis was elicited in Lewis rats by immunization with porcine cardiac myosin. Twenty-eight days after immunization, we investigated the effects of torasemide on metabolic and neurohumoral parameters, cardiac fibrosis and remodeling in experimental autoimmune myocarditis rats. Diuresis was increased dose-dependently by torasemide; the urinary potassium and sodium excretion was significantly decreased and increased, respectively. Myocardial functional parameters measured by hemodynamic and echocardiographic studies were significantly improved by torasemide treatment in a dose-dependent manner. The area of fibrosis, myocyte size and the myocardial protein levels of transforming growth factor-beta1, collagen III, and aldosterone synthase were significantly decreased, and the sarcoplasmic reticulum Ca(2+) ATPase2 protein level was significantly increased by torasemide treatment. Moreover, the plasma levels of angiotensin II and aldosterone were increased and atrial natriuretic peptide was decreased in a dose-dependent manner. Our results indicate that torasemide treatment significantly improved left ventricular function and ameliorated the progression of cardiac remodeling beyond its renal effects in rats with chronic heart failure after experimental autoimmune myocarditis.

    Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy. Publishing Authors By Initials

    pt veeraveeduPT Veeraveedu,k watanabeK Watanabe,m maM Ma,ss palaniyandiSS Palaniyandi,k yamaguchiK Yamaguchi,k suzukiK Suzuki,m kodamaM Kodama,y aizawaY Aizawa,pt veeraveeduPT Veeraveedu,k watanabeK Watanabe,m maM Ma,ss palaniyandiSS Palaniyandi,k yamaguchiK Yamaguchi,k suzukiK Suzuki,m kodamaM Kodama,y aizawaY Aizawa,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: European journal of pharmacology

    VOLUME: 581

    Page Numbers: 121-31

    Journal Abbreviation: Eur. J. Pharmacol.

    ISSN: 0014-2999

    DAY: 28

    MONTH: 11

    YEAR: 2007

    Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 1254354

    Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy.

    AFFILIATION: Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata City, Japan.

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Eur J Pharmacol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News